Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | BMC Complementary and Alternative Medicine

Fig. 4

From: Butylidenephthalide antagonizes cromakalim-induced systolic pressure reduction in conscious normotensive rats

Fig. 4

Effects of butylidenephthalide (Bdph, a), 4-aminopyridine (4-AP, b) and glibenclamide (GBC, c) on log dose–response curves of cromakalim for change of systolic pressure in conscious normotensive rats. All values are shown as mean ± SEM. The number of Bdph-treated rats was 8, and that of 4-AP- or GBC-treated rats was 6. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to their respective control

Back to article page